Safety and efficacy of azacitidine in myelodysplastic syndromes
Carlos E Vigil, Taida Martin-Santos, Guillermo Garcia-ManeroDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAPurpose: The clinical efficacy, different dosages, treatment schedules, and safety of azacitidine are reviewed.Summary: Azacitidine is the first drug...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-09-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/safety-and-efficacy-of-azacitidine-in-myelodysplastic-syndromes-a5251 |